4 Stocks to Watch on Tuesday: BAC, JNJ and More
Wall Street On Edge As Nasdaq Nears Record High, Oil Prices Plummet: Strategist Says There's Opportunity If Resilience Continues
Earnings Snapshot: Johnson & Johnson Tops Q3 Estimates as Darzalex Sales Surge
Johnson & Johnson Expects 2024 Reported Sales Of $88.4B–$88.8B Compared To Prior Guidance Of $88.0B–$88.4B And Consensus Of $88.51B
Johnson & Johnson Non-GAAP EPS of $2.42 Beats by $0.21, Revenue of $22.5B Beats by $330M
Jim Cramer Says Earnings Season Will Fuel Market's Record Run, But Warns Of This 'Horrendous' Headwind That Could Apply Brakes To Rally